$425 Million is the total value of SECTOR GAMMA AS's 33 reported holdings in Q4 2021. The portfolio turnover from Q3 2021 to Q4 2021 was 4.3% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| MRK | Sell | MERCK & CO INC | $36,466,000 | -40.3% | 475,804 | -41.5% | 8.57% | -29.6% |
| CAH | Sell | CARDINAL HEALTH INC | $25,574,000 | -1.3% | 496,680 | -5.1% | 6.01% | +16.4% |
| BMY | Sell | BRISTOL-MYERS SQUIBB CO | $21,735,000 | -17.5% | 348,591 | -21.7% | 5.11% | -2.7% |
| GILD | Sell | GILEAD SCIENCES INC | $21,569,000 | -16.8% | 297,055 | -19.9% | 5.07% | -2.0% |
| BSX | Sell | BOSTON SCIENTIFIC CORP | $21,220,000 | -18.9% | 499,530 | -17.1% | 4.99% | -4.4% |
| BDX | Sell | BECTON DICKINSON & CO | $19,024,000 | -5.2% | 75,647 | -7.3% | 4.47% | +11.8% |
| PFE | Sell | PFIZER INC | $16,853,000 | -39.9% | 285,403 | -56.2% | 3.96% | -29.1% |
| BIIB | Sell | BIOGEN INC | $15,978,000 | -32.2% | 66,599 | -20.1% | 3.76% | -20.1% |
| ANTM | Sell | ANTHEM INC | $15,947,000 | -1.0% | 34,402 | -20.4% | 3.75% | +16.7% |
| CNC | Sell | CENTENE CORP DEL | $15,091,000 | +14.1% | 183,146 | -13.7% | 3.55% | +34.5% |
| BRKR | Sell | BRUKER CORP | $13,658,000 | -25.0% | 162,768 | -30.2% | 3.21% | -11.7% |
| OGN | Sell | ORGANON & CO | $13,146,000 | -26.6% | 431,709 | -20.9% | 3.09% | -13.5% |
| NUVA | Sell | NUVASIVE INC | $12,631,000 | -29.3% | 240,691 | -19.3% | 2.97% | -16.7% |
| QGEN | Sell | QIAGEN NV | $10,941,000 | -35.9% | 196,845 | -40.4% | 2.57% | -24.4% |
| ELAN | Sell | ELANCO ANIMAL HEALTH INC | $9,798,000 | -25.0% | 345,230 | -15.7% | 2.30% | -11.6% |
| LH | Sell | LABORATORY CORP AMER HLDGS | $7,345,000 | -31.1% | 23,377 | -38.3% | 1.73% | -18.8% |
| XRAY | Sell | DENTSPLY SIRONA INC | $6,406,000 | -56.1% | 114,816 | -54.3% | 1.51% | -48.2% |
| IONS | Sell | IONIS PHARMACEUTICALS INC | $6,376,000 | -28.0% | 209,537 | -20.6% | 1.50% | -15.1% |
| UHS | Sell | UNIVERSAL HLTH SVCS INCcl b | $5,866,000 | -15.7% | 45,238 | -10.1% | 1.38% | -0.6% |
| SAGE | Sell | SAGE THERAPEUTICS INC | $4,207,000 | -14.3% | 98,904 | -10.7% | 0.99% | +1.0% |
| RIGL | Sell | RIGEL PHARMACEUTICALS INC | $3,894,000 | -39.5% | 1,469,604 | -17.1% | 0.92% | -28.7% |
| PDCO | Sell | PATTERSON COS INC | $3,608,000 | -29.8% | 122,947 | -27.9% | 0.85% | -17.3% |
| BAX | Exit | BAXTER INTL INC | $0 | – | -237,429 | -100.0% | -3.81% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2022-02-08
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| BOSTON SCIENTIFIC CORP | 40 | Q1 2023 | 9.9% |
| BIO RAD LABS INC | 40 | Q1 2023 | 4.7% |
| BRISTOL-MYERS SQUIBB CO | 38 | Q3 2023 | 11.9% |
| BAXTER INTL INC | 34 | Q3 2023 | 12.7% |
| CARDINAL HEALTH INC | 34 | Q3 2023 | 8.1% |
| PERKINELMER INC | 33 | Q2 2021 | 6.3% |
| BIOGEN INC | 30 | Q3 2023 | 7.6% |
| ELEVANCE HEALTH INC | 30 | Q3 2023 | 5.6% |
| GILEAD SCIENCES INC | 29 | Q3 2023 | 14.0% |
| TENET HEALTHCARE CORP | 28 | Q3 2023 | 4.3% |
View SECTOR GAMMA AS's complete holdings history.
Latest filings
| Type | Filed |
|---|---|
| 13F-HR | 2024-02-05 |
| 13F-HR | 2023-11-06 |
| 13F-HR | 2023-08-09 |
| 13F-HR | 2023-05-12 |
| 13F-HR/A | 2023-02-08 |
| 13F-HR | 2023-02-07 |
| 13F-HR | 2022-11-09 |
| 13F-HR | 2022-08-05 |
| 13F-HR | 2022-05-06 |
| 13F-HR | 2022-02-08 |
View SECTOR GAMMA AS's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.